RxDoctor Payments Data

Terence Myckatyn, MD

Plastic and Reconstructive Surgery · Saint Louis, MONPI 1598781718

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $258,847 of the $399,168 with a category attached, or 64.8%. RTI Surgical, Inc accounts for 91.1% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2021 at $233,321 and has fallen 88.6% since, to $26,531 in 2025. Among plastic and reconstructive surgery clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$399,168in general payments, 2019–2025

Across 98 payments — averaging $4073.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • RTI Surgical, Inc$364K
  • Surgalign Spine Technologies, Inc.$32K
  • AbbVie$2K
  • Acera Surgical, Inc.$430
  • Sientra, Inc.$387
  • Mentor Worldwide LLC$214
  • plus $760 from 9 others
$192,822in research payments, 2019–2025

Across 11 payments — averaging $17,529 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Surgalign Spine Technologies, Inc.$131K
  • AbbVie$62K

What the payments were for

  • Royalty or licence$135,75434%
  • Consulting fees$258,84765%
  • Travel & lodging$1,2310%
  • Food & beverage$3,3361%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$399,168 in reported general payments places this provider in the 95th percentile of 61 plastic and reconstructive surgery providers in Missouri.

See all plastic and reconstructive surgery providers in Missouri

Medicare billing

Part B allowed, 2024
$41,259
Medicare patients
42
Services billed
119

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib26$388
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen26$150
Pregabalin25$123
Cyclobenzaprine Hcl21$82
Tizanidine Hcl11$36
Ondansetron OdtOndansetron22$26

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →